androstenedione has been researched along with Diseases, Metabolic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adaway, J; Keevil, B; Lerchbaum, E; Lindheim, L; Münzker, J; Obermayer-Pietsch, B; Pieber, TR; Trummer, C | 1 |
| Soory, M; Tilakaratne, A | 1 |
2 other study(ies) available for androstenedione and Diseases, Metabolic
| Article | Year |
|---|---|
High salivary testosterone-to-androstenedione ratio and adverse metabolic phenotypes in women with polycystic ovary syndrome.
Topics: Adult; Androstenedione; Anovulation; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Glucose Intolerance; Humans; Insulin Resistance; Metabolic Diseases; Metabolic Syndrome; Phenotype; Polycystic Ovary Syndrome; Saliva; Tandem Mass Spectrometry; Testosterone | 2017 |
Osteoblastic responses to LPS, glucose-oxidised LDL and minocycline: therapeutic targets for periodontal and cardiometabolic diseases.
Topics: Androstenedione; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cardiovascular Diseases; Cells, Cultured; Chromatography, Thin Layer; Dihydrotestosterone; Gas Chromatography-Mass Spectrometry; Glucose; Humans; Lipopolysaccharides; Lipoproteins, LDL; Metabolic Diseases; Minocycline; Osteoblasts; Oxidation-Reduction; Oxidative Stress; Periodontal Diseases; Testosterone; Time Factors; Wound Healing | 2012 |